BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 15148369)

  • 1. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.
    Moshe Y; Boulaire J; Pagano M; Hershko A
    Proc Natl Acad Sci U S A; 2004 May; 101(21):7937-42. PubMed ID: 15148369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.
    Hansen DV; Loktev AV; Ban KH; Jackson PK
    Mol Biol Cell; 2004 Dec; 15(12):5623-34. PubMed ID: 15469984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor emi1.
    Eldridge AG; Loktev AV; Hansen DV; Verschuren EW; Reimann JD; Jackson PK
    Cell; 2006 Jan; 124(2):367-80. PubMed ID: 16439210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis.
    Ma HT; Tsang YH; Marxer M; Poon RY
    Mol Cell Biol; 2009 Dec; 29(24):6500-14. PubMed ID: 19822658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk.
    Golan A; Yudkovsky Y; Hershko A
    J Biol Chem; 2002 May; 277(18):15552-7. PubMed ID: 11859075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase.
    Margottin-Goguet F; Hsu JY; Loktev A; Hsieh HM; Reimann JD; Jackson PK
    Dev Cell; 2003 Jun; 4(6):813-26. PubMed ID: 12791267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the action of early mitotic inhibitor 1 on the anaphase-promoting complex/cyclosome by cyclin-dependent kinases.
    Moshe Y; Bar-On O; Ganoth D; Hershko A
    J Biol Chem; 2011 May; 286(19):16647-57. PubMed ID: 21454540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex.
    Reimann JD; Freed E; Hsu JY; Kramer ER; Peters JM; Jackson PK
    Cell; 2001 Jun; 105(5):645-55. PubMed ID: 11389834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis.
    Eckerdt F; Strebhardt K
    Cancer Res; 2006 Jul; 66(14):6895-8. PubMed ID: 16849530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC.
    Ayad NG; Rankin S; Murakami M; Jebanathirajah J; Gygi S; Kirschner MW
    Cell; 2003 Apr; 113(1):101-13. PubMed ID: 12679038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for the anaphase-promoting complex inhibitor Emi2/XErp1, a homolog of early mitotic inhibitor 1, in cytostatic factor arrest of Xenopus eggs.
    Tung JJ; Hansen DV; Ban KH; Loktev AV; Summers MK; Adler JR; Jackson PK
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4318-23. PubMed ID: 15753281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.
    Watanabe N; Arai H; Nishihara Y; Taniguchi M; Watanabe N; Hunter T; Osada H
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4419-24. PubMed ID: 15070733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex.
    Wei W; Ayad NG; Wan Y; Zhang GJ; Kirschner MW; Kaelin WG
    Nature; 2004 Mar; 428(6979):194-8. PubMed ID: 15014503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1.
    van de Weerdt BC; van Vugt MA; Lindon C; Kauw JJ; Rozendaal MJ; Klompmaker R; Wolthuis RM; Medema RH
    Mol Cell Biol; 2005 Mar; 25(5):2031-44. PubMed ID: 15713655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of Cdc20/fizzy negatively regulates the mammalian cyclosome/APC in the mitotic checkpoint.
    Yudkovsky Y; Shteinberg M; Listovsky T; Brandeis M; Hershko A
    Biochem Biophys Res Commun; 2000 May; 271(2):299-304. PubMed ID: 10799291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xe-p9, a Xenopus Suc1/Cks protein, is essential for the Cdc2-dependent phosphorylation of the anaphase- promoting complex at mitosis.
    Patra D; Dunphy WG
    Genes Dev; 1998 Aug; 12(16):2549-59. PubMed ID: 9716407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitotic regulation of the human anaphase-promoting complex by phosphorylation.
    Kraft C; Herzog F; Gieffers C; Mechtler K; Hagting A; Pines J; Peters JM
    EMBO J; 2003 Dec; 22(24):6598-609. PubMed ID: 14657031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit.
    Littlepage LE; Ruderman JV
    Genes Dev; 2002 Sep; 16(17):2274-85. PubMed ID: 12208850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The APC/C inhibitor, Emi1, is essential for prevention of rereplication.
    Machida YJ; Dutta A
    Genes Dev; 2007 Jan; 21(2):184-94. PubMed ID: 17234884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.